Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03610477 · ClinicalTrials.gov registry record · NA

MiCrobiome dieT Study

A NA study of Healthy, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
34
Enrollment target
1
Study location

NCT03610477 is a NA study of Healthy that has completed, run by University of Minnesota. The registered enrollment target is 34 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03610477, a NA study of Healthy, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target
1
Study location

Study Summary

The human gut microbiome is the community of bacteria that reside within the human intestine. These microbes are constantly exposed to the end-products and partial break-down-products of digestion from the foods consumed each day. Very little is known about the complex interaction of specific dietary components with the microbiome over time in one individual. In order to produce robust analysis of these interactions, longitudinal samples with detailed dietary intake information from healthy human subjects are needed. The complex relationship between dietary intake and the microbiome, and the potential health implications of human exposure to microbial metabolites, are only beginning to be understood. It is well known that altered dietary intake can trigger rapid, although transient, changes in the composition of the microbiome in as little as 1 to 2 days. The biggest factors in determining microbial response to diet are thought to include an individual's starting microbiome, long-term dietary habits, and environmental exposures. It is not well understood how small dietary differences from day-to-day impact the microbiome. A longitudinal dataset with accurately recorded dietary data and multiple samples over 17 days will provide valuable insight into the changes that occur at the individual level over time, while controlling for dietary trends and initial microbiome composition. Medium chain triglycerides (MCTs) have systemic beneficial effects and increase survival in rats by preventing gut injury and permeability following lipopolysaccharide administration, preventing alcohol-induced liver injury, and protecting against the development of colitis in a model of Crohn's disease. Understanding the interaction of MCTs with the microbiome in humans could lead to important advancements in the understanding of how diet impacts the microbiome composition, and ultimately, human health. This proposed study is designed to evaluate the effect of MCTs compared with long chai

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Medium chain triglycerides
  • DIETARY_SUPPLEMENT Long chain triglycerides

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2017-01-01
Est. Completion 2017-12-30
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT03610477

The ClinicalTrials.gov registry entry for NCT03610477 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Medium chain triglycerides is the first listed.

NCT03610477 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT03610477 about?

NCT03610477 is a clinical study titled "MiCrobiome dieT Study". The human gut microbiome is the community of bacteria that reside within the human intestine. These microbes are constantly exposed to the end-products and partial break-down-products of digestion from the foods consumed each day. Very little is known about the complex interaction of specific dietar...

What is the current status of trial NCT03610477?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2017-01-01. Estimated completion is 2017-12-30.

What conditions does trial NCT03610477 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT03610477?

The interventions under investigation include: Medium chain triglycerides (DIETARY_SUPPLEMENT), Long chain triglycerides (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03610477?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03610477 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.